Date/Time: March 28th, 1 PM
Presentation title: Enabling scalable cell engineering using the MaxCyte ExPERT electroporation platform
MaxCyte is a U.S.-based global company leveraging its proprietary electroporation technology to accelerate the discovery, development, manufacturing and commercialization of next-generation medicines. During this presentation, we will explore how MaxCyte’s unique electroporation technology enables highly efficient, scalable engineering of cell lines and primary cells for a range of applications, including transient protein production, cell line development, and cell therapy manufacturing. We will showcase how our partners utilize the MaxCyte platform to shorten timelines, reduce cost, and de-risk cell engineering processes from concept to commercialization.